What the oncologist needs to know about COVID-19 infection in cancer patients

Autor:	Rita-Maria Khoury-Abboud, Tarek Assi, Joseph Kattan, Elie El Rassy, Nathalie Ibrahim, Clarisse Kattan
Rok vydání:	2020
Předmět:	Cancer Research 2019-20 coronavirus outbreak medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Immune checkpoint inhibitors Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clinical Decision-Making Pneumonia Viral coronavirus review Viral transmission Antineoplastic Agents Medical Oncology chemotherapy Antiviral Agents Vulnerable Populations immune checkpoint inhibitors Clinical decision making Neoplasms medicine Humans Intensive care medicine Pandemics Oncologists oncologist business.industry Disease progression COVID-19 Cancer General Medicine medicine.disease Editorial Oncology Disease Progression Coronavirus Infections business
Zdroj:	Future Oncology
ISSN:	1744-8301 1479-6694
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1f27392b2b23bd5a6316dcc1034bca https://doi.org/10.2217/fon-2020-0312 Zobrazit plný text záznamu